Pipeline

Our oncology indications were selected based on already clinically practice visible light delivery to the localized area.


Therapeutics
Pre-Clinical
Clinical

Non-Muscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Cancer 5%

Glioblastoma Multiform

Glioblastoma Multiform 2%

Squamous and Basal Cell Carcinoma

Squamous and Basal Cell Carcinoma 6%